The United States-Mexico bilateral response to the illicit drug market affecting both countries has continued to persevere with an acknowledgement by both that measures to reduce demand are a critical component of their drug strategies. Cooperation between the United States and Mexico in the anti-drug campaign has been manifested in various forms, including law enforcement training, cooperative investigations, and military aid. A central component of bilateral counternarcotics cooperation between the two countries is the High Level Contact Group for Drug Control, or HLCG. Created in 1996, the HLCG brings together counterparts from both countries to discuss the many aspects of the illicit drug market and formulate an effective response. The United States-Mexico Binational Drug Strategy is one of the acclaimed products of this venture. Mexican drug traffickers have become a significant supply source for most of the major drugs consumed in the United States. Across the globe, nations such as the United States and Mexico have forged partnerships to address the problems associated with illegal drugs. In the United States-Mexico experience, there are relevant lessons for countries engaged in cooperative counternarcotics efforts. One such lesson is that the illegal drug market has metastasized at the cost of thousands of lost lives and billions of dollars. References
Downloads
Similar Publications
- Self-reported offending and drug use after prison release: The pernicious role of stress during reentry
- Does variation across judicial circuits matter? Examining the role of bail schedules and pretrial detention on drug case outcomes in Florida
- NPS Discovery Q3 2025 Trend Reports: NPS Benzodiazepines, NPS Opioids, NPS Stimulants &